SecBot SecBot
DEFA14A ·Filed Apr 1, 2026

VKTX

Viking Therapeutics, Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed7mo ago SEC0001193125-26-137924
Proxy solicitation materials
Actionable Insight • Neutral

No trading implications from this filing. Monitor for any unexpected director changes or auditor issues, but this appears to be a standard annual meeting with no surprises.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$34.80
T+0 close · Apr 1, 2026 · via day close
Latest settled
+12.10%
T+60 · $39.01
Vs SPY
−2.06%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Apr 2 $34.80entry
  2. T+1 · 8mo ago −2.50%α −2.98% · $33.93
  3. T+5 · 7mo ago −1.55%α −5.17% · $34.26
  4. T+20 · 7mo ago −10.40%α −20.28% · $31.18
  5. T+60 · 5mo ago +12.10%α −2.06% · $39.01
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Viking Therapeutics is holding its 2026 annual shareholder meeting to vote on director elections, auditor selection, and executive compensation. This is a routine annual filing with no material financial or operational updates.

Key Financial Metrics

Vote
director election
Meeting
2026-05-19
Seats Contested
2

Key Facts

  • Annual shareholder meeting scheduled for May 19, 2026
  • Voting on election of two Class II directors: J. Matthew Singleton and S. Kathryn Rouan, Ph.D.
  • Ratification of CBIZ CPAS P.C. as independent auditors
  • Advisory vote on executive compensation
  • Board recommends approval of all proposals

Financial Impact

No immediate financial impact - routine governance matters

governancecompliance

Risk Factors

  • None identified in this filing
  • Standard risks associated with any corporate governance vote

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
DEFA14A Filing (Primary)0001193125-26-137924
Document: 0001193125-26-137924-index-headers.html0001193125-26-137924
Document: 0001193125-26-137924-index.html0001193125-26-137924
Document: 0001193125-26-137924.txt0001193125-26-137924

Track record

13 reports on VKTX

Performance horizon

5 of 5 bullish or bearish reports moved the stock their way by T+1. Best: +31.38% at T+20 after the Sep 24, 2026 report. 5 of 5 went positive at some point.

Filters
  1. Nov 5, 202611d ago SC 13G/A Neutral 3/10 Entry $25.79 to $26.84 Now $26.80 +3.92% ▲ +4.07% +3.76% vs SPY
  2. Oct 28, 202619d ago 8-K Neutral 5/10 Entry $26.86 to $27.28 Now $26.80 −0.22% ▲ +1.56% +3.34% vs SPY
  3. Oct 23, 202624d ago Institutional Cluster Bearish 4/10 Entry $24.40 to $24.21 Now $26.80 −9.84% ▲ +0.78% +1.49% vs SPY
  4. Oct 21, 202626d ago Press Release Neutral 1/10 Entry $25.83 to $24.40 Now $26.80 +3.76% ▼ −5.54% −5.01% vs SPY
  5. Sep 28, 20267w ago 8-K Mixed 6/10 Entry $31.81 to $32.60 Now $26.80 −15.75% ▲ +2.48% +2.69% vs SPY
  6. Sep 24, 20267w ago 424B5 Bearish 5/10 Entry $35.56 to $33.03 Now $26.80 +24.63% ▲ +7.11% +6.37% vs SPY
  7. Sep 24, 20267w ago 424B5 Bearish 6/10 Entry $35.56 to $33.03 Now $26.80 +24.63% ▲ +7.11% +6.37% vs SPY
  8. Sep 23, 20267w ago 424B5 Neutral 4/10 Entry $36.75 to $35.56 Now $26.80 −27.07% ▼ −3.24% −3.78% vs SPY
  9. Sep 23, 20267w ago 424B5 Bearish 6/10 Entry $36.75 to $35.56 Now $26.80 +27.07% ▲ +3.24% +3.78% vs SPY
  10. Sep 22, 20267w ago 8-K Bullish 7/10 Entry $40.85 to $41.65 Now $26.80 −34.39% ▲ +1.96% +2.68% vs SPY
Showing 10 of 13

US Market Status

Market Closed · Opens in 8h 55m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 1, 2026